Growth Metrics

Innoviva (INVA) EBT Margin Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -2,817.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,558.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -683.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 2,688.00
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn 28,290.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 28,290.00
Dec 31, 2025 -42,065.00
Sep 30, 2025 8,309.00
Jun 30, 2025 11,171.00
Mar 31, 2025 -471,476.00
Dec 31, 2024 -42,286.00
Sep 30, 2024 -12,014.00
Jun 30, 2024 -63,167.00
Mar 31, 2024 -49,712.00
Dec 31, 2023 55,219.00
Sep 30, 2023 -2.19 Mn
Jun 30, 2023 -49,608.00
Mar 31, 2023 155,038.00
Dec 31, 2022 -37,116.00
Sep 30, 2022 2.19 Mn
Jun 30, 2022 -1.06 Mn
Mar 31, 2022 -852,378.00
Dec 31, 2021 -1.86 Mn
Sep 30, 2021 6,895.00
Jun 30, 2021 1.15 Mn
Mar 31, 2021 1.20 Mn
Dec 31, 2020 1.79 Mn
Sep 30, 2020 -3,069.00
Jun 30, 2020 6,149.00
Mar 31, 2020 3,266.00
Dec 31, 2019 90.00
Sep 30, 2019 628.00
Jun 30, 2019 373.00
Mar 31, 2019 3,003.00
Dec 31, 2018 4,799.00
Sep 30, 2018 1,138.00
Jun 30, 2018 2,304.00
Mar 31, 2018 1,642.00
Dec 31, 2017 -1,334.00
Sep 30, 2017 2,499.00
Jun 30, 2017 2,170.00
Mar 31, 2017 2,301.00
Dec 31, 2016 3,810.00
Sep 30, 2016 7,876.00
Jun 30, 2016 11,296.00
Mar 31, 2016 17,316.00
Dec 31, 2015 23,760.00
Sep 30, 2015 212,326.00
Jun 30, 2015 205,443.00
Mar 31, 2015 191,993.00
Dec 31, 2014 38,504.00
Sep 30, 2014 12,102.00
Jun 30, 2014 -201,116.00
Mar 31, 2014 64,384.00
Dec 31, 2013 -63,876.00
Sep 30, 2013 14,794.00
Jun 30, 2013 698,095.00
Mar 31, 2013 -278,570.00
Dec 31, 2012 72,513.00
Sep 30, 2012 -194,979.00
Jun 30, 2012 -670,551.00
Mar 31, 2012 42,757.00